| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. | Director | Common Stock | 27.7K | $28.1K | $1.02 | 06 Jan 2025 | Direct |
| OptiNose, Inc. | Director | Stock Option (Right to Buy) | 32K | 08 Jun 2022 | Direct | ||
| Acurx Pharmaceuticals, Inc. | Director | Warrants for Common Stock | 24.6K | 06 Jan 2025 | Direct | ||
| Acurx Pharmaceuticals, Inc. | Director | Stock Option | 12K | 17 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACXP | Acurx Pharmaceuticals, Inc. | 06 Jan 2025 | 2 | $25K | 4 | Director | 08 Jan 2025, 16:32 |
| ACXP | Acurx Pharmaceuticals, Inc. | 17 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:15 |
| ACXP | Acurx Pharmaceuticals, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 17:45 |
| OPTN | OptiNose, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 10:13 |
| ACXP | Acurx Pharmaceuticals, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 06 Jul 2021, 16:15 |
| ACXP | Acurx Pharmaceuticals, Inc. | 24 Jun 2021 | 0 | $0 | 3 | Director | 24 Jun 2021, 18:24 |
| OPTN | OptiNose, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 15:11 |
| OPTN | OptiNose, Inc. | 10 May 2021 | 1 | $29.9K | 4 | Director | 11 May 2021, 14:27 |